Chronic Posttraumatic Stress Disorder Clinical Trial
Official title:
Brief Eclectic Psychotherapy for PTSD - a Randomized Controlled Trial
Verified date | January 2010 |
Source | University of Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Swissmedic |
Study type | Interventional |
Participants are randomly assigned to either 16 sessions of Brief Eclectic Psychotherapy (Gersons et al. (2000) Journal Trauma Stress 13: 333-348), comprising psychoeducation, exposure, mementos and writing assignments, domain of meaning and integration, farewell ritual, or a minimal attention control group that will be offered 16 sessions of BEP after a waiting time of four months. Participants in the minimal attention control group receive monthly telephone calls and complete a symptom self monitoring diary (Tarrier, N. et al. (1999) Behavior Therapy 30: 597-605) for three weeks.
Status | Completed |
Enrollment | 30 |
Est. completion date | December 2009 |
Est. primary completion date | May 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Clear memory of an "index" traumatic event (sufficient for constructing a scene to be used in exposure) that occurred no less than six months prior to entering the trial (Montgomery and Bech 2000) - PTSD according to the DSM-IV, related to the index traumatic event, as measured with the CAPS: frequency = 1 and intensity = 2 for a symptom to be counted plus a minimum level of overall severity = 50 - Not receiving other psychotherapy for PTSD during the 16 weeks of active treatment; psychotherapy for other problems, brief check-ins with an existing therapist, and attendance at self-help groups will be allowed - If on psychoactive medication: on a stable medication regimen for a minimum of two months prior to entering the trial - Aged between 18 and 70 years - Sufficient proficiency in the German language to participate in BEP - Consent to be randomized into the trial Exclusion Criteria: - Current psychotic, bipolar, substance-related, or severe personality disorder - Current severe depressive disorder - Severe cognitive impairment or a history of organic mental disorder - Evidence of PTSD or depression immediately prior to the index trauma - Ongoing threat of traumatic exposure - Prominent current suicidal or homicidal ideation - Asylum seeking status |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Switzerland | Psychiatric Department, University Hospital | Zurich |
Lead Sponsor | Collaborator |
---|---|
University of Zurich | Herrmann-Klaus-Stiftung, Switzerland, Jubiläumsspende für die Universität Zürich, Switzerland, Olga Mayenfisch Stiftung, Zurich, Switzerland, Swiss National Science Foundation |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | PTSD symptom severity (CAPS, Blake et al. 1998; Post-therapy / post-waitlist comparison, controlled for baseline scores | Last month | No | |
Secondary | Ability to work and use of health care facilities | Last months | No | |
Secondary | Comorbidity: Structured Clinical Interview for DSM-IV SCID I (First et al. 1996); Hospital Anxiety and Depression Scale HADS (Zigmond and Snaith 1983) | Last month | No | |
Secondary | Questions on Life Satisfaction FLZ (Henrich and Herschbach 2000) | Last month | No | |
Secondary | Posttraumatic Cognitions Inventory PTCI (Foa et al. 1999) | Last month | No | |
Secondary | Posttraumatic Growth Inventory PGI (Tedeschi and Calhoun 1996) | Since trauma | No | |
Secondary | EEG, event-related potentials: P300 | At assessment | No | |
Secondary | Post-therapy / post-waitlist comparison, follow-up at 6month post therapy | Last month | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01188694 -
Enhancing Extinction Learning in Post Traumatic Stress Disorder (PTSD)
|
Phase 2 | |
Completed |
NCT01024140 -
Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder
|
N/A | |
Terminated |
NCT01574118 -
Enhancing Exposure Therapy for Post-traumatic Stress Disorder
|
Phase 2 |